Clinical Trials Browser

Recruiting × HER2-positive Breast Cancer × Ado-Trastuzumab Emtansine × Clear all

NCT06313086 2024-05-10

DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer

Phase 3 Recruiting

HER2-positive Breast Cancer